January 27, 2022
Greg Fonzo, PhD
and
There is a recent and growing resurgence of interest in the potential for psychedelic compounds to be utilized as treatments for mood and anxiety disorders. Learn about a broad overview of the history, current clinical practice, and potential therapeutic mechanisms underlying psilocybin-assisted psychotherapy.
July 1, 2021
Annmarie MacNamara, PhD
and
Research Feature - Mapping An Anxiety Spectrum: A Neurobiological Marker of Severity and Prognosis In Mood and Anxiety Disorders
#ADAA2021Virtual Donald F. Klein Awardee Research Presentation
August 26, 2021
Stephanie Woodrow, LCPC, NCC
and
Tejal Jakatdar, PhD
and
Webinar Featuring ADAA Member Stephanie Woodrow, LCPC, NCC & Tejal Jakatdar, PhD.
June 11, 2021
Larry Cohen, LICSW, A-CBT
and
June 11 & 18 - Live CE/CME Eligible webinar presented by Larry Cohen, LCSW
October 29, 2020
Sandra S. Pimentel, PhD
and
Mona Potter, MD
and
Krystal M. Lewis, PhD - ADAA Board Member
and
Lynn Lyons, LICSW
and
Jamie Micco, PhD, ABPP
and
John T. Walkup, MD
and
August 27, 2020
Erika Vivyan, PhD
and
Participants discussed and learned to apply behavioral principles from Parent Management Training (PMT) and Parent-Child Interaction Training (PCIT) to Exposure and Response Prevention. Then, participants discussed a case example involving behavioral treatment for Selective Mutism, Separation Anxiety Disorder, and Oppositional Defiant Disorder.
June 8, 2020
Yaara Shimshoni, PhD
and
Eli Lebowitz, PhD
and
This webinar presents attendees with an overview of family accommodation and its associations with child anxiety and provide an introduction to the SPACE Program. Clinical trials in anxiety and OCD support the ability of SPACE to reduce family accommodation children's symptoms. Results of a recently completed funded randomized clinical trial of SPACE are presented and discussed.
May 28, 2020
Medical Marijuana Laws & Evidence for Harmful/Beneficial Effects in Depression and Anxiety Disorders
Rajiv Radhakrishnan MBBS, MD
and
Kevin A. Sabet, PhD
and
April 20, 2020
Sheila Rauch, PhD, ABPP
and
The current COVID-19 pandemic is unprecedented in reach around the world and the extended nature of this invisible threat. All are impacted whether it is direct impact on health or employment or indirect impact through availability of services and loved ones.
June 3, 2020
Lauren P. Wadsworth, PhD
and
This webinar discusses population specific components of anxiety and depression development (e.g. role of stigma, coming out), and provides tangible ways to provide more accurate and affirming research, and/or more culturally informed therapy.
